News summary

Peptide Update

Source: Aging Matters - Dr. J. Mitteldorf • Published: 04 Nov 2026, 19:47

Summarized by Masters of Longevity from Aging Matters - Dr. J. Mitteldorf.

A large, linguistically isolated clinical literature reports mortality-linked benefits in elderly cohorts.

Peptide Update
Key Takeaways
  • The program reported multi-year elderly cohorts with mortality endpoints.
  • Evidence was concentrated within a single Russian research network.
  • Independent Western replication and modern randomized trials remain lacking.
Read the full article at Aging Matters - Dr. J. Mitteldorf ↗

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?